Your browser is no longer supported. Please, upgrade your browser.
INO Inovio Pharmaceuticals, Inc. daily Stock Chart
Inovio Pharmaceuticals, Inc.
Index- P/E- EPS (ttm)-1.21 Insider Own2.20% Shs Outstand103.87M Perf Week8.92%
Market Cap240.98M Forward P/E- EPS next Y-0.85 Insider Trans-50.79% Shs Float94.32M Perf Month-6.45%
Income-116.60M PEG- EPS next Q-0.26 Inst Own41.90% Short Float12.37% Perf Quarter-13.75%
Sales7.50M P/S32.13 EPS this Y2.90% Inst Trans0.08% Short Ratio21.30 Perf Half Y-39.90%
Book/sh0.55 P/B4.22 EPS next Y20.80% ROA-74.30% Target Price9.13 Perf Year-57.97%
Cash/sh1.02 P/C2.28 EPS next 5Y0.00% ROE-144.80% 52W Range1.91 - 5.68 Perf YTD-42.00%
Dividend- P/FCF- EPS past 5Y6.10% ROI-110.80% 52W High-59.15% Beta2.04
Dividend %- Quick Ratio4.60 Sales past 5Y17.70% Gross Margin- 52W Low21.15% ATR0.15
Employees281 Current Ratio4.60 Sales Q/Q-99.60% Oper. Margin- RSI (14)53.78 Volatility8.99% 6.45%
OptionableYes Debt/Eq1.17 EPS Q/Q-311.40% Profit Margin- Rel Volume0.76 Prev Close2.25
ShortableYes LT Debt/Eq1.17 EarningsNov 07 AMC Payout- Avg Volume547.56K Price2.32
Recom1.60 SMA207.53% SMA502.43% SMA200-28.47% Volume422,481 Change3.11%
Feb-15-18Reiterated Maxim Group Buy $12 → $8
Oct-18-17Initiated RBC Capital Mkts Outperform $11
Sep-06-17Initiated Citigroup Buy $10
Jun-08-17Upgrade Piper Jaffray Neutral → Overweight
May-24-17Reiterated Maxim Group Buy $10 → $12
Mar-16-17Upgrade Maxim Group Hold → Buy $10
Mar-16-17Downgrade Piper Jaffray Overweight → Neutral
Nov-07-16Initiated Aegis Capital Buy
Aug-09-16Downgrade Maxim Group Buy → Hold
Mar-15-16Reiterated Stifel Buy $19 → $13
Jan-05-16Reiterated Maxim Group Buy $23 → $14
Sep-09-15Reiterated Maxim Group Buy $20 → $23
Mar-12-15Initiated H.C. Wainwright Buy $17
Jul-24-14Upgrade Aegis Capital Hold → Buy $10 → $19
May-07-14Initiated Stifel Buy $4
Mar-18-14Reiterated Maxim Group Buy $3 → $6
Jan-24-14Reiterated Brean Capital Buy $3 → $4
Aug-16-13Downgrade Aegis Capital Buy → Hold
Jul-09-13Reiterated Maxim Group Buy $1 → $2
Mar-11-13Initiated Aegis Capital Buy $1.50
Oct-10-19 08:42AM  QIAGEN Inks Deal With Illumina to Deliver NGS-Based IVD Kits Zacks
Sep-25-19 02:49AM  Edited Transcript of INO earnings conference call or presentation 8-Aug-19 8:30pm GMT Thomson Reuters StreetEvents
Sep-17-19 09:00AM  Inovio Receives NIH Funding to Target its dMAb® Technology Against Antimicrobial-Resistant Infection PR Newswire -6.69%
Sep-07-19 09:30AM  Inovio (INO) Down 16.1% Since Last Earnings Report: Can It Rebound? Zacks
Sep-03-19 09:00AM  Inovio Pharmaceuticals to Present at Upcoming Investor Conferences PR Newswire
Aug-26-19 04:49PM  Inovio (INO) Down More Than 30% in 3 Months: Here's Why Zacks
Aug-20-19 05:14PM  Inovio Ends Enrollment in Anal Dysplasia Study on VGX-3100 Zacks
Aug-19-19 09:00AM  Inovio Completes Enrollment of its VGX-3100 Open-label Phase 2 Trial for Treatment of HPV-Related High-Grade Anal Dysplasia PR Newswire
Aug-09-19 01:23PM  Inovio Pharmaceuticals, Inc. (INO) Q2 2019 Earnings Call Transcript Motley Fool
11:16AM  Inovio (INO) Q2 Earnings & Revenues Fall Shy of Estimates Zacks
Aug-08-19 06:05PM  Inovio Pharmaceuticals (INO) Reports Q2 Loss, Lags Revenue Estimates Zacks
04:05PM  Inovio Pharmaceuticals Reports 2019 Second Quarter Financial Results PR Newswire
Aug-07-19 10:19AM  Montco biotech could become first U.S. company listed on Nasdaq, Korean exchanges American City Business Journals
Aug-06-19 04:05PM  Inovio Closes $15 Million Private Placement of Convertible Bonds to Institutional Investors in Korea PR Newswire -5.88%
Aug-01-19 10:33AM  Earnings Preview: Inovio Pharmaceuticals (INO) Q2 Earnings Expected to Decline Zacks
Jul-30-19 10:38AM  Earnings Preview: Inovio Pharmaceuticals (INO) Q2 Earnings Expected to Decline Zacks
09:00AM  Inovio Pharmaceuticals to Report Second Quarter 2019 Financial Results on August 8, 2019 PR Newswire
Jul-25-19 09:00AM  Inovio's Positive First-in-Human MERS Vaccine Results Published in The Lancet Infectious Diseases PR Newswire
Jul-17-19 11:20AM  Inovio (INO) Ends Some Early-Stage R&D Programs, Cuts Jobs Zacks -9.67%
09:16AM  Why Inovio Pharmaceuticals Stock Is Plunging Today Motley Fool
Jul-16-19 08:08PM  Inovio narrows focus, eliminates 80 jobs American City Business Journals
04:05PM  Inovio Sharpens Focus On HPV-Related Diseases And Fast-to-Market Product Candidates PR Newswire
11:08AM  Should You Worry About Inovio Pharmaceuticals, Inc.'s (NASDAQ:INO) CEO Salary Level? Simply Wall St.
Jul-10-19 08:00AM  Geneos Therapeutics Announces First Patient Dosed with its DNA-based, Neoantigen-Targeting Personalized Vaccine Technology PR Newswire
Jul-09-19 09:54AM  Inovio Ends Enrollment in Vulvar Dysplasia Study on VGX-3100 Zacks
Jul-08-19 09:00AM  Inovio Completes Enrollment of VGX-3100 Phase 2 Trial for the Treatment of HPV-Related Vulvar Dysplasia (VIN) PR Newswire
Jun-27-19 10:18AM  Inovio Up on Enrollment Closure in Cervical Dysplasia Study Zacks
Jun-26-19 09:47AM  Inovio Completes Enrollment of VGX-3100 Phase 3 Trial (REVEAL 1) for the Treatment of HPV-Related Cervical Pre-cancer PR Newswire +19.84%
Jun-25-19 09:28AM  Inovio Inks $35M Chinese Drug License Deal (INO) Investopedia
Jun-10-19 03:55PM  Inovio Pharmaceuticals, Inc. (NASDAQ:INO): Time For A Financial Health Check Simply Wall St.
09:00AM  Inovio Receives $8.14 Million Award to Support Further Development of its Commercial Skin Delivery Device PR Newswire
Jun-08-19 09:31AM  Inovio (INO) Down 36.7% Since Last Earnings Report: Can It Rebound? Zacks
Jun-06-19 11:54AM  State picks next president of Georgia Tech American City Business Journals
Jun-04-19 11:15AM  Inovio Pharmaceuticals Inc (INO) CEO Jong Joseph Kim Sold $5 million of Shares +5.49%
May-31-19 11:25AM  Why Inovio Pharmaceuticals Stock Is Sinking Today Motley Fool -14.95%
May-29-19 07:38AM  The Daily Biotech Pulse: Inovio's Partner Scales Back R&D Collaboration, Genmab Seeks Nasdaq Listing, Bayer Gets Breakthrough Therapy Designation Benzinga
May-28-19 08:38PM  After Hours: DowDuPont Spinoff Leaping to the S&P 500, Inovio's Partner Problems Motley Fool
06:19PM  Inovio Pharma stock slips as AstraZeneca unit scales back agreement MarketWatch
05:27PM  Stocks making the biggest moves after hours: Workday, Inovio and more CNBC
May-21-19 09:00AM  Inovio First to Advance Lassa Fever Candidate Vaccine Into a Clinical Trial PR Newswire
May-17-19 11:53AM  QIAGEN Partners Inovio to Develop Companion Diagnostics Zacks
08:03AM  The Daily Biotech Pulse: Axovant Doses First Patient In Gene Therapy Trial, Agile Resubmits NDA, ADMA Prices Offering Benzinga
May-16-19 04:02PM  Inovio and QIAGEN Establish Collaboration to Develop Diagnostic Test for VGX-3100, Inovio's Novel Immunotherapy Targeting Advanced Cervical Pre-Cancer PR Newswire
May-15-19 09:00AM  Inovio and Plumbline Life Sciences Establish Animal Health Collaboration to Develop A Novel Vaccine Against Deadly African Swine Fever Virus PR Newswire
May-10-19 10:21AM  Inovio (INO) Q1 Earnings & Revenues Fall Short of Estimates Zacks
06:00AM  What You'll Want to Know About Inovio Pharmaceuticals' Q1 Earnings Update Motley Fool
03:49AM  Edited Transcript of INO earnings conference call or presentation 9-May-19 8:30pm GMT Thomson Reuters StreetEvents
02:23AM  Inovio Pharmaceuticals Inc (INO) Q1 2019 Earnings Call Transcript Motley Fool
May-09-19 06:25PM  Inovio Pharmaceuticals (INO) Reports Q1 Loss, Misses Revenue Estimates Zacks
05:19PM  Inovio: 1Q Earnings Snapshot Associated Press
04:05PM  Inovio Pharmaceuticals Reports 2019 First Quarter Financial Results PR Newswire
02:48PM  If You Had Bought Inovio Pharmaceuticals (NASDAQ:INO) Stock Three Years Ago, You'd Be Sitting On A 58% Loss, Today Simply Wall St.
May-07-19 04:48PM  What's in the Cards for AcelRx (ACRX) This Earnings Season? Zacks -6.08%
07:53AM  What's in Cards for Cumberland (CPIX) This Earnings Season? Zacks
May-06-19 09:38AM  What's in the Cards for Corbus (CRBP) This Earnings Season? Zacks
09:00AM  Inovio Receives European Medicines Agency Certification For Quality and Non-Clinical Data for Its Phase 3 Product, VGX-3100 PR Newswire
May-02-19 04:39PM  Protalix (PLX) to Report Q1 Earnings: What's in the Cards? Zacks
May-01-19 10:32AM  Inovio Pharmaceuticals (INO) Expected to Beat Earnings Estimates: Should You Buy? Zacks
09:00AM  Inovio Pharmaceuticals to Report First Quarter 2019 Financial Results on May 9, 2019 PR Newswire
Apr-18-19 02:43PM  Cover story: Joseph Kim's art of the bio-deal American City Business Journals
09:00AM  Inovio Publishes Cancer Killing Data of Its Transformative DNA-encoded Bi-specific T Cell Engagers (dBiTEs) in a Peer-reviewed Journal PR Newswire
06:00AM  Inovio- A Biotech Bet for New World Investors MoneyShow
Apr-17-19 09:00AM  Inovio's Phase 3 HPV Immunotherapy Selected As "Best Therapeutic Vaccine" at World Vaccine Congress PR Newswire -5.34%
Apr-11-19 09:30AM  Inovio (INO) Up 10.7% Since Last Earnings Report: Can It Continue? Zacks
Apr-09-19 11:37AM  One Thing To Remember About The Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Share Price Simply Wall St.
10:30AM  Inovio Earns 3rd Milestone Fee From AstraZeneca for MEDI0457 Zacks
Apr-08-19 09:00AM  Inovio Achieves Third Cancer Indication Milestone for MEDI0457 Phase 2 Development PR Newswire
Apr-04-19 10:36AM  Inovio's HPV Candidate Shows Efficacy in Pilot Study, Stock Up Zacks
Apr-03-19 09:00AM  Inovio's Novel HPV Therapy INO-3106 Demonstrates Clinical Efficacy Against Rare Respiratory Tract Tumors in Pilot Clinical Study PR Newswire
Apr-02-19 10:51AM  Inovio Closes Enrollment in Brain Cancer Study Before Time Zacks
07:45AM  Inovio Presents Cancer Killing Data of Its Transformative DNA-Encoded Bi-specific T Cell Engagers (dBiTEs) at AACR PR Newswire
Apr-01-19 07:45AM  Inovio Completes Enrollment Ahead of Schedule In Immuno-Oncology Study for Glioblastoma (GBM) with INO-5401 in Combination with Regeneron's PD-1 Inhibitor PR Newswire
Mar-27-19 07:45AM  Inovio Pharmaceuticals to Present at H.C. Wainwright Global Life Sciences Conference in London, UK PR Newswire
Mar-25-19 07:45AM  Inovio Appoints Global Commercial Leader to its Board of Directors PR Newswire
Mar-21-19 09:11AM  Inovio's Ebola Vaccine Delivered Intradermally Demonstrates 100% Immunogenicity in a Clinical Study Published in The Journal of Infectious Diseases PR Newswire
08:42AM  Inovio Pharmaceuticals stock up 9% after company announces positive data from Phase 1 trial of Ebola vaccine MarketWatch
08:18AM  Inovio's Ebola Vaccine Delivered Intradermally Demonstrates 100% Immunogenicity in a Clinical Study Published in The Journal of Infectious Diseases PR Newswire
Mar-20-19 12:35AM  Edited Transcript of INO earnings conference call or presentation 12-Mar-19 8:30pm GMT Thomson Reuters StreetEvents
Mar-18-19 11:28AM  Inovio's Early/Mid-Stage Vaccine Pipeline Exhibits Growth Zacks
Mar-13-19 10:03AM  Inovio (INO) Misses on Q4 Earnings & Revenues, Shares Down Zacks
05:04AM  Inovio Pharmaceuticals (INO) Q4 2018 Earnings Conference Call Transcript Motley Fool
Mar-12-19 06:15PM  Inovio Pharmaceuticals (INO) Reports Q4 Loss, Lags Revenue Estimates Zacks
05:19PM  Inovio Pharmaceuticals Earnings: INO Stock Dips as Q4 Revenue Declines InvestorPlace
05:10PM  Inovio: 4Q Earnings Snapshot Associated Press
04:10PM  Inovio Pharmaceuticals Reports 2018 Fourth Quarter and Year-End Financial Results PR Newswire
11:59AM  C-suite shuffle at Inovio Pharmaceuticals American City Business Journals
08:00AM  Inovio Appoints Chief Operating Officer; Announces Strategic Management Changes PR Newswire
Mar-08-19 02:16PM  Imagine Owning Inovio Pharmaceuticals (NASDAQ:INO) And Trying To Stomach The 75% Share Price Drop Simply Wall St. -5.92%
Mar-06-19 08:42AM  Why Inovio Pharmaceuticals Stock Broke Down in February Motley Fool -5.26%
Mar-05-19 08:00AM  Inovio Pharmaceuticals to Announce Fourth Quarter and Full Year 2018 Financial Results and Host Conference Call on March 12, 2019 PR Newswire
Mar-04-19 08:00AM  Inovio Initiates REVEAL 2 Global Phase 3 Clinical Study For the Treatment of HPV-Related Cervical Pre-cancer PR Newswire
Mar-01-19 11:22AM  Inovio Pharmaceuticals Completes Sale of Additional Convertible Senior Notes PR Newswire
Feb-28-19 10:17AM  Inovio spinoff developing patient-specific cancer therapies raises $10.5M American City Business Journals
Feb-25-19 12:41PM  Small Cap Winners And Losers From Last Week Benzinga
Feb-21-19 08:00AM  Geneos Therapeutics Secures $10.5 Million in Series A Financing to Develop the Next Generation of Neoantigen-Targeting Cancer Immunotherapies PR Newswire
Feb-20-19 08:00AM  Inovio Announces First Subject Dosed with its DNA-Encoded Monoclonal Antibody (dMAb) In First-Ever Human Trial PR Newswire
07:30AM  Recent Analysis Shows NVIDIA, Molson Coors Brewing, Invacare, The Blackstone Group, Inovio Pharmaceuticals, and Tech Data Market Influences Renewed Outlook, Key Drivers of Growth GlobeNewswire
Feb-15-19 09:47AM  Montco biopharm firm plans $65M note sale; stock drops by 22 percent American City Business Journals
Feb-14-19 12:00PM  Here's Why Inovio Pharmaceuticals Is Getting Beaten Down Today Motley Fool -21.15%
07:50AM  The Daily Biotech Pulse: Vanda Q4 Results, Inovio Debt Offering, Caladrius Diabetes Drug Flunks Mid-Stage Trial Benzinga
Inovio Pharmaceuticals, Inc., a late-stage biotechnology company, focuses on the discovery, development, and commercialization of DNA-based immunotherapies and vaccines to prevent and treat cancers and infectious diseases. Its SynCon immunotherapy design has the ability to break the immune system's tolerance of cancerous cells, as well as is intended to facilitate cross-strain protection against known, as well as new unmatched strains of pathogens, such as influenza. The company is involved in conducting and planning clinical studies of its proprietary SynCon immunotherapies for human papillomavirus-caused pre-cancers and cancers; glioblastoma multiforme; hepatitis B virus; hepatitis C virus; human immunodeficiency virus; Ebola virus; middle east respiratory syndrome; and Zika virus. Its partners and collaborators include The Wistar Institute; University of Pennsylvania; GeneOne Life Science Inc.; ApolloBio Corporation; Regeneron Pharmaceuticals, Inc.; Genentech, Inc.; Plumbline Life Sciences, Inc.; Drexel University; National Institute of Allergy and Infectious Diseases; United States Military HIV Research Program; U.S. Army Medical Research Institute of Infectious Diseases; National Institutes of Health; HIV Vaccines Trial Network; Defense Advanced Research Projects Agency; the Parker Institute for Cancer Immunotherapy; QIAGEN N.V.; and Coalition for Epidemic Preparedness Innovations. Inovio Pharmaceuticals, Inc. was founded in 1979 and is headquartered in Plymouth Meeting, Pennsylvania.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Humeau LaurentChief Scientific OfficerAug 30Buy2.224,5009,99050,333Sep 04 09:57 AM
Weiner David B.DirectorAug 01Sale2.7216,35244,477797,110Aug 02 05:00 PM
Humeau LaurentChief Scientific OfficerJun 05Buy2.5020,00050,00045,833Jun 05 05:19 PM
Kim Jong JosephChief Executive OfficerJun 03Sale2.31296,705684,736816,527Jun 04 09:00 AM
Kim Jong JosephChief Executive OfficerJun 03Sale2.30832,8481,914,4681,078,207Jun 04 09:00 AM
Kim Jong JosephChief Executive OfficerMay 31Sale2.40500,0001,200,8001,113,232Jun 04 09:00 AM
Kim Jong JosephChief Executive OfficerMay 31Sale2.44500,0001,217,6501,911,055Jun 04 09:00 AM
Kim Jong JosephChief Executive OfficerMay 21Sale3.31100,000331,0002,411,055May 23 04:21 PM
Kim Jong JosephChief Executive OfficerMay 16Sale3.5061,212214,2421,613,232May 17 04:44 PM
Kim Jong JosephChief Executive OfficerMay 15Sale3.5075,556264,4461,674,444May 17 04:44 PM
DHILLON AVTAR SDirectorDec 06Option Exercise2.0025,00050,000106,002Dec 06 05:17 PM
KIES PETERCFONov 29Option Exercise2.0010,00120,00272,089Nov 30 05:27 PM
KIES PETERCFONov 29Sale5.2810,00152,80562,088Nov 30 05:27 PM